As we have already reported (Woodruff, 1982a; 1984b) , many in vitro -propagated cloned cell lines, and some uncloned lines, from strongly immunogenic methylcholanthrene-induced murine fibrosarcomas fail to grow when transplanted s.c.
(1-2 x 106 viable cells) to normal syngeneic hosts, whereas cells from the primary tumours that have not been propagated in vitro are readily transplantable. A similar decline in tumorigenicity in vivo as a consequence of propagation in vitro has been reported in respect of murine respiratory carcinomas by Jamasbi & Nettesheim (1977 .
In our experiments, cell lines that failed to grow in normal adult syngeneic mice grew readily in thymectomized, heavily irradiated (7.3 Gy) syngeneic mice protected with cytosine arabinoside, sublethally irradiated (4.7 Gy) syngeneic mice, and syngeneic or allogeneic adult nude mice, and after such passage usually grew in normal mice. To account for these findings we postulated firstly that in vitro passaged lines are susceptible in vivo to combined attack by T cells and NK (or similar) cells but may escape if either component is missing; and secondly that, during passage in hosts deficient in T but not NK cells, a tumour cell population emerges that is NK cell resistant and can therefore grow in normal mice. The expression "NK (or similar) cells" is used here in a broad sense to include all cells which exhibit cell-mediated cytotoxicity which is non-acquired, i.e. is not contingent on previous specific priming or non- specific activation of some kind.
In the mouse there are at least two kinds of cell which conform to this definition, distinguished inter alia by the kinetics of target cell lysis, expression of cell-surface antigens, and age at which their activity first becomes manifest. There is much to be -said for referring to these simply as NK (type 1) and NK (type 2) cells, but in the absence of any general agreement to this effect we have reluctantly adopted Stutman's terminology (Stutman et al., 1978) , using NK as the label for cells which kill in short term (4 h) in vitro assays, and NC for those whose activity is demonstrated only in more prolonged (15-24 h) assays, despite the objection that both categories of cell are cytotoxic and cytocidal.
To investigate the matter further we have embarked on a comparative study of the tumorigenicity, immunogenicity, sensitivity to cellmediated cytotoxicity (CMC) and surface markers of cultured lines, and lines passaged in normal and deprived hosts, including newborn normal and athymic (CBA nu/nu) mice. These last two categories were added to those tested previously because both have been reported to show little or no evidence of NK (as distinct from NC) activity these cells in vitro, will be reported in a subsequent paper. Here we present the results of in vivo studies on the tumorigenicity and immunogenicity of cultured and mouse-passaged lines, and discuss possible reasons for the differences observed.
Materials and methods
Tumours and clones Forty-six cloned cell lines were studied in all, derived from three different fibrosarcomas, designated W319 (previously referred to as Dl 1), W321 (D13) and W324 (S10), which had been induced with methylcholanthrene in female CBA backcross mice heterozygous for the A and B alloenzymes of phosphoglycerate kinase-1 (PGK-1). The origin and properties of these tumours, and the techniques of tissue culture, transplantation, cloning and alloenzyme analysis, have been described previously (Woodruff et al., 1982a) .
Cultured cloned lines (C lines) were maintained by repeated subculture and samples were stored from time to time in liquid nitrogen. Mousepassaged lines (M lines) were established by passage in an irradiated mouse followed by repeated passage in normal mice. Cells from M lines were sometimes grown for 24 or 48 h in culture before being used experimentally; these are referred to as MC cells.
There were 20 PGK-l A clones (W319 clones 6, 7, 10, 13, 15, 16, 18, 24, 25, 27, 30, 35, 36, 37, 40; W321 clone 7; W324 clones 10, 17, 23, 27) , 22 PGK-I B clones (W319 clones 1-5, 8, 9, 11, 12, 14, 17, 23, 26, 28, 29, 32, 33, 34; W324 clones 30, 32, 49, 57) If tumours developed they were measured as described above. The numbers of cells used for challenge depended on the clone used and the number of generations for which it had been passaged in vitro. The dose chosen was such that tumours in control mice reached their end point in 2-3 weeks. The immunogenicity index (I) was calculated as previously described (Woodruff et al., 1982b) (Table III) . One mouse-passaged line (W319 C6M), which After injection of the cultured line (Figure 1 ) two phases can be distinguished, with a markedly higher specific rate from Day 6 onwards. We attribute this higher rate to the development of an immune reaction to TATA since it did not occur in irradiated mice.
After injection of mouse-passaged cells ( Figure 2 ) the specific rate of loss was relatively high for 24h (not plotted in detail), possibly owing to the presence in the inoculum of labelled dead or damaged cells. From Day 1 to Day 5 the rate was slower than the initial rate, and slower also than the rate observed with cultured cells at the corresponding time. Thereafter the rate increased in normal but not in irradiated mice, and once again we attribute this increase to the development of immunity to tumour antigens.
After injection of irradiated (220 Gy) labelled cultured or mouse-passaged cells to normal mice, label was lost more quickly than after injection of viable cells of the same kind, and the specific rate of loss appeared to increase continuously after 24h, with no clear-cut distinction between phase 2 and phase 3. Figures 3 and 4 .
Pre-treatment with irradiated cells (whether cultured or mouse-passaged), or non-irradiated cultured cells, 14 days before challenge with viable mouse-passaged cells (Figure 4) , prevented the development of tumours and resulted in accelerated disappearance of label. It seems clear, therefore, that cultured and mouse-passaged cells are both immunogenic, and the results do not point to any clearcut difference in their level of immunogenicity. Mice challenged with cultured cells did not develop tumours, irrespective of whether or not they were pre-immunized, but pre-immunization did result in somewhat accelerated loss of label (Figure 3 ).
When mice with established tumours caused by injection of viable mouse-passaged cells were challenged with a further injection of labelled mouse-passaged cells to the opposite hind limb, tumours developed rapidly at the site of challenge and the pattern of disappearance of label was indistinguishable from that seen in previously untreated mice. In these experiments, therefore, there is no evidence of concomitant immunity. Pretreatment with frozen-thawed cells did not generate detectable immunity (not plotted). (Jamasbi & Nettesheim, 1977 . The tumours were reported to be initially highly tumorigenic and weakly immunogenic, but to become less tumorigenic and strongly immunogenic after prolonged tissue culture, and the difference in tumorigenicity was attributed to the difference in immunogencity. In many of these experiments the mice received an immunizing injection of viable cells followed by amputation of the tumour-bearing limb and rechallenge. These are difficult to interpret because metastases frequently developed from the initial inoculum and it seems likely that they influenced the response to challenge, but other experiments, referred to by Jamasbi et al. but The growth in vivo of a transplanted strongly immunogenic tumour implies that it has somehow escaped from T cell-mediated surveillance, and this in turn implies either that the inoculum contained T cell resistant tumour cells or that resistance developed sufficiently quickly for the tumour to survive despite the reaction it evoked. Our data show that the capacity to escape may be lost in the course of tissue culture but may be regained in vivo if the tumour is transplanted to a host which, on account of T cell or other deficiency, is unable to destroy all the potentially tumorigenic cells sufficiently quickly to prevent this from happening.
We suggested previously that the capacity of our tumours to grow in normal mice is lost during culture because, owing to lack of selective pressure, a population of cells emerges which is susceptible to destruction by both NK and/or NC cells and T cells, and that, during passage in mice deficient in T but not NK cells, these are replaced by cells which are NK-or NC-resistant, possibly owing to a surface change which makes them unrecognisable as appropriate targets, but remain sensitive to T cells. On re-transplantation to a normal mouse these passaged tumour cells then become established sufficiently quickly for further changes to occur so that the developing tumour is able to resist the Tcell mediated reaction it evokes.
In the light of the reported absence of significant NK activity in newborn mice and our observation that cultured lines passaged in newborns subsequently grew readily in normal adult mice, this hypothesis seems unlikely to be correct so far as 1)n I\ -I NK cells are concerned, though pending further evidence it cannot be excluded with certainty. So far as NC cells are concerned there are at present no grounds for rejecting the hypothesis, but there are two other possibilities which merit consideration.
Firstly, during passage in a susceptible host, the tumour cells might acquire a protective cell-surface molecule that interferes, possibly in a non-specific way, with the efferent, though not the afferent, arm of the immune response. This is certainly conceivable because antigen released from cells could immunize whereas only antigen on the cell surface provides a target for either cell-mediated or humoral cytotoxicity.
Secondly, during passage, the tumour cells might lose a molecule necessary for recognition by T cells. The mouse-passaged tumours used in this study clearly do not lack TATA but a class I MHC molecule would seem to be a candidate since the phenomenon of MHC restriction (Zinkernagel & Doherty, 1975) raises the possibility that loss of an MHC molecule required for dual recognition may provide an escape mechanism for immunogenic tumours (Woodruff, 1980) . Experiments are in progress to try to distinguish between these possibilities and to characterize the molecule or molecules concerned.
